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Abstract
Staphylococcus aureus is both a common colonizer of human skin and the most frequently isolated pathogen in diabetes foot infections
(DFIs). The spread of DFI to soft tissue and bony structures is a major causal factor for lower-limb amputation. It is therefore of great
importance to differentiate colonizing from infecting strains of S. aureus. Epidermal cell differentiation inhibitors known as EDIN and EDIN-
like factors, a group of toxins targeting RhoA master regulator of the actin cytoskeleton, may confer virulence properties on S. aureus. In
this study, for the ﬁrst time, analysis of S. aureus strains, recovered in DFIs at an initial stage and during the follow-up, showed that 71.4% of
edin-positive strains were associated with moderate-to-severe infections (grades 3 and 4 of the IDSA/IWGDF classiﬁcation) compared with
28.6% of edin-positive strains associated with low-grade infections. Most of these strains were edin-B positive (86.7%) and belonged to
CC25/28-MSSA (n = 10). One edin-B-positive ST152-MSSA strain was negative for the two highly prevalent predictive markers of infecting
strains (lukDE and hlgv). Collectively, this points towards the edin-B encoding gene as a bonaﬁde subsidiary predictive risk marker of DFI.
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Foot ulcers are common in diabetic patients, with a
prevalence rate as high as 25% [1]. These ulcers frequently
become infected, and spread of infection to soft tissue and
bony structures is a major causal factor for lower-limb
amputation [2]. Staphylococcus aureus is the most frequently
isolated pathogen in diabetic foot infections (DFIs). Both the
occurrence and progression of staphylococcal infection result
from the action of a variety of virulence factors combined
with the immunological status of the host [3, 4]. Bacterial
factors are extremely heterogeneous in structure and mode
of action, giving the bacteria speciﬁc metabolic and adhesive
properties, as well as offering them a protection against the
large body of innate immune effectors [3]. Deﬁning the
contributing role of virulence factors by combining cellular
microbiological techniques and epidemiological approaches
would be of interest in predicting S. aureus-associated risk of
pejorative infections [5].
The epidermal differentiation factor (EDIN) and EDIN-like
factors of S. aureus belong to such factors of well-determined
mode of action, although their implication in staphylococcal
infection remains ill deﬁned. EDIN belongs to a family of
bacterial exotoxins targeting the small host protein RhoA,
which they inhibit [6, 7]. This small GTPase is a major
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regulator of the host cell actin cytoskeleton [8]. Several cell
biology studies have revealed that inhibition of RhoA has a
detrimental impact on the cohesion of epithelium and
endothelium barriers, which is likely to favour bacterial
dissemination [9, 10]. Inhibition of RhoA also impairs
complement-mediated phagocytosis [11]. As a whole, a large
number of studies aimed at investigating the impact of RhoA
inhibition, point towards a contributing role of EDIN factors
in bacterial colonization and host tissue invasion [5, 12]. Thus
deﬁning the distribution of edin-encoding genes in clinical
isolates of S. aureus might help in predicting the risk factors
for severe and spreading infection.
A previous multicentre study conducted on clinical isolates
of S. aureus had suggested that two clonal complexes (CC) and
an array of virulence factors can be used to discriminate
uninfected from infected diabetic foot ulcers (DFUs) [13].
Indeed, we determined that colonizing S. aureus strains (grade
1) with a favourable outcome are linked to the clonal
complexes CC5/CC8. In parallel, we deﬁned a group of
virulence factors associated with worse outcomes of DFU,
notably sea, sei, lukDE and cap8 [14]. Reﬁned analysis of
virulence factors associated with infecting strains, using DNA
array technology, identiﬁed two highly prevalent factors, lukDE
and hlgv, as suitable genetic markers to predict risk of infection
by S. aureus (p <0.005). Nevertheless, it would be interesting
to determine additional markers, which might be used to
discriminate a higher number of colonizing from infecting
strains of S. aureus in DFU. We therefore analysed the
distribution of edin genes in clinical isolates of S. aureus
responsible for diabetic foot infection (DFI) in a French
national collection of 195 isolates.
Patients and Methods
Study design
We prospectively enrolled a sample of outpatients attending
one of 12 participating French foot clinics between 1 April
2008 and 30 June 2010 for any type of DFU, after informed
consent was obtained (Fig. 1). This study was approved by the
local ethics committee (South Mediterranean III) and carried
out in accordance with the Declaration of Helsinki as revised
in 2000. Patients were included if they had not received any
antibiotic agents in the previous week. Every patient was
examined by trained physicians to grade infection severity.
According to the IDSA-IWGDF criteria [15, 16], wounds were
considered either uninfected (grade 1) or infected (grade  2).
After wound debridement, samples for bacterial culture were
obtained by swabbing the wound base, needle aspiration or
tissue biopsy and immediately sent to the bacteriology
department. Only patients with monomicrobial culture for
S. aureus were included in the study. Antibiotic treatment was
not prescribed in patients with uninfected ulcers. Thereafter,
patients were closely monitored for 30 days to deﬁnitively
assess the wound status (infected/uninfected). If the wound
condition was worsening before the follow-up visit, patients
were instructed to return to the outpatient department for
early review and a further sample was taken for bacterial
culture. At the follow-up visit, if the wound was healing but not
completely re-epithelialized, a sample for bacterial culture was
obtained, and the outcome was considered as favourable. For
completely re-epithelialized wounds, no microbiological spec-
imens were sampled and the wound was considered healed.
Microbiological study
Genus, species and antibiotic susceptibilities were determined
using the Vitek 2 card (BioMerieux, Marcy-l’Etoile, France) and
interpreted according to the recommendations of the French
Society for Microbiology [17]. Susceptibility to methicillin was
screened by agar diffusion using cefoxitin disks (BioRad,
Marnes-La-Coquette, France) [17].
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FIG. 1. Flowchart of the study.
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Oligonucleotide DNA arrays to determine EDIN-isoforms
Each S. aureus strain collected during the study was analysed at
the INSERM laboratory in N^ımes, France. The Alere Staphy-
Type DNA microarray was used according to protocols and
procedures previously detailed [18, 19]. The test was able to
screen numerous markers simultaneously in 5 hours. The
DNA microarray covers 334 target sequences including two
edin-isofoms: edinA and edinB. Primer and probe sequences
have been published previously [18, 19]. DNA was extracted
from each S. aureus strain and after ampliﬁcation and hybrid-
ization, markers were identiﬁed. This technology determines
the clonal complex (CC) of strains. A CC may be best deﬁned
as a cluster of strains (clones) that are close enough together
to be claimed to share a common origin. Thus this group of
bacteria is genetically identical to a single ancestral clone. This
afﬁliation of isolates was assessed by an automated comparison
of hybridization proﬁles with a collection of reference strains
previously characterized [18, 19].
Statistical analysis
The presence of each gene in S. aureus strains was compared
according to the ulcer grades and the outcome of ulcers using
Fisher’s exact test. The performances of the edin-isoforms for
diagnosing grade 4 DFU were assessed as usual. Statistical
analysis was performed using the S-PLUS 2000 software package
(Insightful Corporation, Seattle, WA, USA) and results were
considered signiﬁcant for p <0.05.
Results
Clinical and bacterial data
During the study period, 195 patients were enrolled. At
baseline, seventy-ﬁve wounds (38.5%) were classiﬁed as
uninfected and 120 as infected (Fig. 1). During the follow-
up period, 18 patients (24%) returned to the outpatient
department because of a rapidly worsening wound: four
developed a grade 2 ulcer, 12 a grade 3 ulcer and two a
grade 4 ulcer. At the follow-up visit, 33 patients (44%) had
their wound not fully re-epithelialized: a sample for bacterial
culture was obtained, and the outcome was considered as
favourable. In 24 patients (32%), the wound was considered
healed.
At baseline, S. aureus isolate was found to be positive for
edin (A and B) genes in 14 patients (7.2%): six isolates were
recovered from the patients with clinically uninfected DFUs
(8%) and eight from patients with infected DFUs (7%). Six of
those 14 patients (43%) had a grade 4 DFI compared with six
of the 187 patients (3%) in whom S. aureus was edin-negative
(p <0.0003, Table 1). Other clinical characteristics were
identical for both groups (Table 1). Moreover, no signiﬁcant
differences in infection outcomes were found in the 75
patients of the uninfected group, whether the strains were
positive or negative for edin.
During the follow-up period, 24 of the initially uninfected
wounds completely healed, whereas 33 improved without
being closed and 18 worsened. No S. aureus strain from the
healed wounds was initially positive for edin genes. From the
six uninfected DFUs with edin-positive S. aureus, four had a
favourable outcome (66.7%), whereas two (33.3%) worsened
rapidly ( 30 days) with occurrence of a grade 4 DFI. Of note,
an S. aureus strain was isolated from the second bacterial
sampling carried out in those uninfected ulcers that were not
completely healed at the follow-up visit, whether the outcome
was favourable or not.
Collectively, here we determined that edin-positive strains
of S. aureus were more frequently recovered from severe
grade 3/4 ulcers.
Distribution of edin-A, B encoding genes
The prevalence of edin-positive isolates was 7.2% (14/195).
DNA array analysis revealed that among the 14 edin-positive
S. aureus strains, only one (0.5%) was edin-A positive whereas
13 (6.7%) were edin-B positive. The edin-A-positive strain of
S. aureus was recovered from a colonizing sample. The edin-B-
positive strains were recovered from colonizing samples in ﬁve
patients and in eight patients suffering from grade 3/4 infected
ulcers.
In the second bacterial sampling carried out in those
uninfected ulcers that were not completely healed, edin-B-
positive S. aureus was recovered only from the two rapidly and
severely worsening DFUs. In the four DFUs with favourable
outcome, the strains isolated at follow-up no longer harboured
any edin-isoforms; moreover, these strains were not the same
as initially assessed by difference in their CCs.
If we used the edin-isoforms to differentiate localized
infections (grade 2–3) from systemic infections (grade 4),
sensitivity was 0.5, speciﬁcity 0.96, and positive and negative
predictive values 0.43 and 0.97, respectively. Moreover, if we
used the edin-isoforms to predict outcome of initially unin-
fected DFUs, sensitivity was very poor (11.1%) but speciﬁcity
high (93.0%); positive and negative predictive values were
33.3% and 76.8%, respectively.
Main characteristics of edin+ S. aureus isolates
The univariate analysis found that eight genes were signiﬁcantly
associated with edin-positive isolates: lukDE, hlgv, lukS-PV lukF-
PV, etD, cap5, ﬁb, splA and splB (p <0.05). In contrast, four
genes (cap8, sea, cna and the regulator agrII) were signiﬁcantly
associated with edin-negative strains (p <0.001).
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In 12 strains, edin-B and etD genes were found to be
associated. They were all positive for the sarA gene regulon,
which can control edin-B expression [20]. Ten of these strains
belonged to the agrI cluster. Five of these ten patients had a
grade 4 DFU. Regarding the virulence proﬁles of these ten
isolates, all the strains carried the following genes: the
haemolysin-encoding genes (hlgv, hla and hlb), the egc cluster
of enterotoxins, the genes encoding leukocidin lukDE, the
genes encoding intracellular adhesion proteins (icaA, icaC and
icaD), cap5, and ﬁve genes encoding MSCRAMM (clfA, clfB, ﬁb,
ebpS and fnbA). Of note, cna and fnbB genes were absent
whereas tet and fosB encoding resistance genes were always
present.
As shown in Table 2, the edin-positive S. aureus isolates
displayed a low clonal diversity compared with the other
strains (40 CCs). None of the edin-positive isolates belonged
to CC5/CC8. A total of three known CCs and one unknown
singleton were identiﬁed. CC25/28 methicillin-sensitive
S. aureus (MSSA) (n = 10, 76.9%) was the most common CC
in edin-positive strains. This CC and the CC80-MRSA (Euro-
pean Community MRSA Clone, n = 3) were signiﬁcantly
associated with edin-positive isolates (p <0.01). The edin-B-
positive singleton isolated from a grade 4 ulcer was found to
be negative for etD. It was identiﬁed as ST152-MSSA negative
for lukDE and hlgv. This reinforced the interest of using edin-B,
together with the highly prevalent markers lukDE and hlgv, to
decipher strains of S. aureus with a high potential for infection
in DFI.
Discussion
DFUs are prone to infections that may spread systematically
and lead to amputation of lower extremities and possibly to
death. From a clinical point of view, differentiating colonization
from infection may be problematic in DFUs due to the masking
impact of the neuropathy and/or ischemia [15]. Monomicrobial
DFI thus represents a unique model in humans to compare the
distribution of bacterial factors between infecting and colo-
nizing strains of S. aureus. Although the virulence potential of
S. aureus relies on the combination of multiple factors, those
associated with colonizing strains of grade 1 DFUs have
probably a poor contributing role in virulence and notably in
invasion. In this multicentre study, we found that among the 14
edin-positive S. aureus isolates, ten were recovered from deep
grade 3 or 4 infections (at baseline or during follow-up).
Moreover, in the four other edin-positive cases in which
outcomes were favourable, the strains isolated at follow-up
TABLE 1. Demographic and clinical characteristics of the study population
Characteristics
Patients with edin(+) S. aureus Patients with edin() S. aureus Total p
n = 14 n = 181 n = 195 edin vs. total
Age (range), y 69 (58–91) 66 (33–101) 66.5 (33–101) NS
Male/female, n (%) 8 (57.1)/6 (46.9) 131 (72.4)/50 (27.6) 139 (71.3)/56 (28.7) NS
Type 1/Type 2 diabetes mellitus 3/11 26/155 29/166 NS
HbA1c (%) 8.4  2.9 8.3  2.4 8.3  2.2 NS
Cardiovascular disease
Absence 5 (35.7) 49 (27.1) 54 (27.7) NS
Coronary heart disease 6 (42.9) 57 (31.5) 63 (32.3) NS
Peripheral arterial disease 8 (57.5) 114 (63.0) 122 (62.6) NS
Arterial hypotension 12 (85.7) 142 (78.5) 154 (79.0) NS
Stroke 2 (14.4) 14 (7.7) 16 (8.2) NS
Nephropathy
Absence 5 (35.7) 64 (35.4) 69 (35.4) NS
Microalbuminuria 3 (21.4) 47 (26.0) 50 (25.6) NS
Proteinuria 3 (21.4) 48 (26.5) 51 (26.2) NS
Renal failure 5 (35.7) 57 (31.5) 62 (31.8) NS
Neuropathy
Peripheral 10 (71.4) 177 (97.8) 187 (95.9) NS
Autonomic 0 (0) 40 (22.1) 40 (20.5) NS
Retinopathy
Absence 7 (50) 72 (39.8) 79 (40.5) NS
Non-proliferative diabetic retinopathy 6 (42.8) 85 (47.0) 91 (46.7) NS
Proliferative diabetic retinopathy 1 (7.1) 30 (16.6) 31 (15.9) NS
Lifestyle factors
Obesity 4 (28.6) 73 (40.3) 77 (39.5) NS
Smoking 3 (21.4) 51 (28.2) 54 (27.7) NS
Alcoholism 3 (21.4) 25 (13.8) 28 (14.4) NS
Sedentary 8 (57.1) 139 (76.8) 147 (75.4)
First wound/recurrence 3 (21.4)/11 (78.6) 48 (26.5)/133 (73.5) 51 (26.2)/144 (73.8) NS
IDSA grade
1 6 (42.8) 69 (38.1) 75 (38.5) NS
2 0 (0) 38 (21.0) 38 (19.5) NS
3 2 (14.4) 68 (37.6) 70 (35.9) NS
4 6 (42.8) 6 (3.3) 12 (6.1) 0.0003
Outcome of Grade 1 ulcers (1 month after enrollment)
Complete healing 0 (0) 24 (13.3) 24 (32) NS
Improved 4 (66.7) 29 (16.0) 33 (44) NS
Worsening 2 (33.3) 16 (8.8) 18 (24) NS
Values are median and interquartile ranges (25th to 75th percentile) or numbers and percentages. NS, non-signiﬁcant.
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were no longer positive for edin and were from different CCs.
These ﬁndings suggest that these edin-positive strains were
successfully removed during debridement, allowing coloniza-
tion of wounds by other strains. At least, these ﬁndings clearly
indicate that edin genes have a higher prevalence in S. aureus
from high-grade ulcer isolates.
Three alleles of edin have been characterized [21–23]. They
all share similar biochemical activities toward Rho proteins but
are encoded within different genetic backgrounds. The gene
encoding edin-A is located on a plasmid, as for edin-C and the
closely associated exfoliative toxin-B encoding gene [22]. edin-
B is chromosomally encoded within a highly variable pathoge-
nicity island in close proximity to exfoliative toxin-D encoding
gene [20,23]. Although the DNA array we used did not
efﬁciently detect the edin-C gene (unpublished data), the
absence of detection of the exfoliative type-D strongly
suggests that edin-C-positive strains were not present in this
type of infection. Thus, edin-B is the most prevalent edin gene
associated with DFIs.
The clonal complex analysis indicates that edin-positive
strains belonged to four major groups: a singleton near CC8
(edin-A, n = 1), a singleton belonging to ST152-MSSA (edin-B,
n = 1), CC80-MRSA (edin-B, n = 2) and CC25/28-MSSA (edin-
B, n = 10). Here we identiﬁed an edin-B-positive/et-D-negative
strain that belongs to ST152-MSSA. Importantly, this strain
appeared negative for the haemolysin (hlgv) and the leukocidin
(lukDE) genes, which have been deﬁned as two highly prevalent
virulence markers of infectious strains in DFU. Given that the
edinB-positive ST152 strain of S. aureus was isolated from a
Grade 4 ulcer, this result further emphasizes the interest in
screening edin-B as a surrogate maker to discriminate coloniz-
ing from infecting strains of S. aureus in DFU. It is worth noting
that none of the edin-positive S. aureus belonged to CC5/CC8;
two CCs claimed to be predictive of a favourable out-
come [13].
Our analysis of the distribution of edin in DFU supports the
idea that edin might work together with the arsenal of S. aureus
virulence factors to give the bacteria a higher potential for
infection [5, 12]. In keeping with this concept, previous studies
indicated that EDIN factors might favour induction of deep-
seated infectious foci [24,25]. Edin encoding genes thus
represent additional markers of interest to differentiate
infecting from colonizing Staphylococcus aureus strains in DFU
and to predict the wound outcome. Our results highlight the
potential usefulness of the molecular biology in patients in
whom the clinical diagnosis of infection is made difﬁcult by
peripheral arterial disease, neuropathy or impaired leukocyte
functions [26]. The DNA microarray might provide important
help for clinicians and might allow adequate management of
uninfected ulcers carrying S. aureus, according to its genotype
proﬁle. The detection of some CCs and virulent genes in grade
1 ulcers raises the question about antibiotic treatment in
apparently uninfected DFU and challenges the dogma about
abstention of antibiotic therapy in clinically uninfected ulcers.
Indeed, the absence of CC5/CC8 corresponding to colonizing
strains and the presence of CC25/28 and/or of lukDE, hlgv and
edin genes suggest the need for antibiotic treatment as a
therapeutic strategy. However, to date the techniques we used
are largely in the ﬁeld of research.
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